Abstract
Cardiovascular disease remains the most common cause of death worldwide, yet there is a wide variation in disease prevalence between different ethnic groups. Ones individual risk is not entirely explained by ‘traditional’ risk factors and this, along with the observation that endogenous and lifestyle risk factors appear to cluster in the same individuals has led to the idea that there may be a common mechanism underlying this disease. It has been postulated that inflammatory pathways may be important. Results from our own and other studies have demonstrated that there may be ethnic differences in the level of circulating inflammatory markers which may be partially related to demographic, lifestyle or genetic factors. Before it is possible to add inflammatory markers to global risk scores it is imperative that a clear understanding of their function, normal range and major determinants in different ethnic groups is established. To date the ethnic research in this area has been very sparse and further work is urgently required. The usefulness of these inflammatory markers in the diagnosis and prognosis of disease in these different populations also needs to be investigated before therapeutic strategies can be fully developed.
Keywords: Inflammation, ethnicity, cardiovascular disease, cytokines, innate immunity, cardiovascular risk
Current Medicinal Chemistry
Title: Ethnicity and Inflammatory Pathways - Implications for Vascular Disease, Vascular Risk and Therapeutic Intervention
Volume: 14 Issue: 13
Author(s): M. A. Miller and F. P. Cappuccio
Affiliation:
Keywords: Inflammation, ethnicity, cardiovascular disease, cytokines, innate immunity, cardiovascular risk
Abstract: Cardiovascular disease remains the most common cause of death worldwide, yet there is a wide variation in disease prevalence between different ethnic groups. Ones individual risk is not entirely explained by ‘traditional’ risk factors and this, along with the observation that endogenous and lifestyle risk factors appear to cluster in the same individuals has led to the idea that there may be a common mechanism underlying this disease. It has been postulated that inflammatory pathways may be important. Results from our own and other studies have demonstrated that there may be ethnic differences in the level of circulating inflammatory markers which may be partially related to demographic, lifestyle or genetic factors. Before it is possible to add inflammatory markers to global risk scores it is imperative that a clear understanding of their function, normal range and major determinants in different ethnic groups is established. To date the ethnic research in this area has been very sparse and further work is urgently required. The usefulness of these inflammatory markers in the diagnosis and prognosis of disease in these different populations also needs to be investigated before therapeutic strategies can be fully developed.
Export Options
About this article
Cite this article as:
Miller A. M. and Cappuccio P. F., Ethnicity and Inflammatory Pathways - Implications for Vascular Disease, Vascular Risk and Therapeutic Intervention, Current Medicinal Chemistry 2007; 14 (13) . https://dx.doi.org/10.2174/092986707780831131
DOI https://dx.doi.org/10.2174/092986707780831131 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Current Update on Eosinophilic Lung Diseases and Anti-IL-5 Treatment
Recent Patents on Anti-Infective Drug Discovery Cerebral Inflow and Outflow Discrepancies in Severe Sudden Sensorineural Hearing Loss
Current Neurovascular Research Socioeconomic Position and Type 2 Diabetes Mellitus in Europe 1999- 2009: a Panorama of Inequalities
Current Diabetes Reviews Clopidogrel High On-Treatment Platelet Reactivity in Patients with Carotid Artery Stenosis Undergoing Endarterectomy. A Pilot Study
Current Vascular Pharmacology Is there a Relationship between Endothelial Dysfunction of the Brachial Artery, Carotid Intima-Media Thickness and Soluble Receptors of Tumor Necrosis Factor-Alpha?
Vascular Disease Prevention (Discontinued) Atherogenic Index of Plasma in Women with Rheumatoid Arthritis and Systemic Lupus Erythematosus: A 10-Year Potential Predictor of Cardiovascular Disease
Current Rheumatology Reviews Inhibition of Tumor Angiogenesis by Antibodies, Synthetic Small Molecules and Natural Products
Current Medicinal Chemistry Oxidative Stress Biology and Cell Injury During Type 1 and Type 2 Diabetes Mellitus
Current Neurovascular Research Drug Discovery and Design for Complex Diseases through QSAR Computational Methods
Current Pharmaceutical Design Erythropoiesis Stimulating Agents and Anaemia of End-Stage Renal Disease
Cardiovascular & Hematological Agents in Medicinal Chemistry Lipoproteins, Stroke and Statins
Current Vascular Pharmacology Advances in Antiplatelet Therapy for Stroke Prevention: the New P2Y12 antagonists
Current Drug Targets Endothelial Dysfunction and Coronary Atherosclerosis
Current Drug Targets - Cardiovascular & Hematological Disorders Energy Remodeling, Mitochondrial Disorder and Heart Failure
Current Pharmaceutical Design Animal Models for Studying Neointima Formation
Current Vascular Pharmacology Sympathetic Overactivity in Hypertension and Cardiovascular Disease
Current Vascular Pharmacology Lipid Disorders in Diabetes Mellitus and Current Management
Current Pharmaceutical Analysis Prevalence of Pre-Existing Risk Factors for Adverse Events Associated with Atypical Antipsychotics Among Commercially Insured and Medicaid Insured Patients Newly Initiating Atypical Antipsychotics
Current Drug Safety Anti-Inflammatory Approaches to Reduce Acute Cardiovascular Events: Not Only Benefits
Current Pharmaceutical Biotechnology Impact of COVID-19 Infection on Maternal and Neonatal Outcomes: A Review of 11078 Pregnancies Reported in the Literature
Current Women`s Health Reviews